Nieuwe pagina aangemaakt met '<!-- Hieronder wordt een transclude page aangeroepen --> {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.9.6(EN)|1|MedicationAgreement-v4.0(2024EN)}} <!-- Tot hier de transclude page --> ==General information<!--hdGeneralInformation-->== Name<!--hdName-->: '''nl.zorg.MedicationAgreement''' link=Medicatieafspraak-v4.0(2024NL)<BR> Version<!--hdVersion-->: '''4.0''' <br> HCIM Status<!--hdStatus-->:Final<br> Release<!--hdPublication-->: '''…'
MedicatieAfspraak - Vervangen van de verwijzing naar Probleem
Concept
A medication agreement is a prescriber’s proposal for a patient to use medication. An agreement to discontinue the use of medication is also a medication agreement.
Purpose
The goal of the medication agreement is to provide insight into the agreements reached between the prescriber and the patient on the use of medication.
Information Model
Type
Id
Concept
Card.
Definition
DefinitionCode
Reference
NL-CM:9.6.9580
MedicationAgreement
Root concept of the MedicationAgreement information model. This root concept contains all data elements of the MedicationAgreement information model.
Appointment date + time are required (order of the appointments must be clear in cases with multiple appointments on one day)
NL-CM:9.6.19936
PeriodOfUse::TimeInterval
1
Start date: This is the time at which the agreement was to take effect (or took effect or will take effect). This is the time at which the instructions for use in this agreement start. In the case of an agreement to discontinue use, this is the start date of the original medication agreement. The end date indicates from when the medication is to be discontinued.
Duration: The intended duration of use. E.g. 5 days or 8 weeks. It is not allowed to indicate the duration in months, because different months have a variable duration in days.
End date: The time at which the period of use ends (or ended or will end). In the case of an agreement to discontinue use, this is the time at which the medication is to be discontinued. To avoid confusion between 'to' and 'up until and including', the submission of time is always mandatory for the end date.
With medication for an indefinite period only a start date is indicated.
Permitted units for the duration: hour, day, week, year.
Additional information includes details on the structure of the agreement made that are relevant for pharmacovigilance and fulfillment by the pharmacist. This can be used e.g. to indicate that there was a conscious decision to deviate from the norm or that the agreement is to be structured in a certain way.
See also the Instructions section for more information about use of the element.
Technical specifications in HL7v3 CDA and HL7 FHIR
To exchange information based on health and care information models, additional, more technical specifications are required.
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:
HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment
HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR
MedicationAgreement
Diagnosis
or as spreadsheet 